Issue 2, 2013

Synthesis of multi-antigenic platforms as vaccine candidates against cancers

Abstract

Cancer cells are characterized by the presence of diverse antigens on their surface. The combination of these structures in a single molecule represents an attractive strategy to obtain vaccine candidates with improved immunological properties. Herein we report the synthesis of a mixture of heterotopic platforms bearing the Tn and TF carbohydrate antigens and an immunostimulating poliovirus peptide.

Graphical abstract: Synthesis of multi-antigenic platforms as vaccine candidates against cancers

Supplementary files

Article information

Article type
Letter
Submitted
12 Sep 2012
Accepted
21 Nov 2012
First published
23 Nov 2012

New J. Chem., 2013,37, 286-289

Synthesis of multi-antigenic platforms as vaccine candidates against cancers

M. Fiore, B. Thomas, V. Duléry, P. Dumy and O. Renaudet, New J. Chem., 2013, 37, 286 DOI: 10.1039/C2NJ40972K

To request permission to reproduce material from this article, please go to the Copyright Clearance Center request page.

If you are an author contributing to an RSC publication, you do not need to request permission provided correct acknowledgement is given.

If you are the author of this article, you do not need to request permission to reproduce figures and diagrams provided correct acknowledgement is given. If you want to reproduce the whole article in a third-party publication (excluding your thesis/dissertation for which permission is not required) please go to the Copyright Clearance Center request page.

Read more about how to correctly acknowledge RSC content.

Social activity

Spotlight

Advertisements